Opinion

Video

The Use of Ultra-Low PSA in Specific Patient Profiles

Research explores the effectiveness of Aerote in treating metastatic hormone-sensitive prostate cancer, focusing on patient subgroups and genetic factors.

Patient Selection for Ultra-Low PSA Monitoring

Key Themes:

  • Identification of patient profiles most likely to benefit from ultra-low PSA monitoring
  • Relevance for specific risk categories
  • Potential applications in high-volume disease or triplet therapy

Expert Insights:

  • Dr Shore identified specific patient profiles or risk categories where the ultra-low PSA threshold might be particularly valuable.

He discussed its potential relevance for patients with high-volume disease, those receiving triplet therapy, or patients demonstrating rapid initial PSA declines.

Related Videos
Doctor consulting patient | Image Credit: © Liudmila Dutko - stock.adobe.com
Stacy Loeb, MD, MSc, PhD (Hon), answers a question during a Zoom video interview
1 expert in this video
2 experts are featured in this series.
1 expert is featured in this series.
2 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.